BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1955936)

  • 1. AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining.
    Trerè D; Farabegoli F; Cancellieri A; Ceccarelli C; Eusebi V; Derenzini M
    J Pathol; 1991 Sep; 165(1):53-9. PubMed ID: 1955936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
    Trerè D; Ceccarelli C; Danova M; Derenzini M
    Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of silver binding nucleolar organizer regions (AgNORs) in proliferative lesions of bronchi, colon and thyroid--semiautomatic computer image analysis].
    Zaczek M
    Folia Med Cracov; 1996; 37(1-2):67-88. PubMed ID: 9312528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells.
    Derenzini M; Sirri V; Trerè D; Ochs RL
    Lab Invest; 1995 Oct; 73(4):497-502. PubMed ID: 7474921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the occurrence of silver-staining nucleolar organizer regions (AgNORs) in non-proliferating and proliferating tissues.
    Leek RD; Alison MR; Sarraf CE
    J Pathol; 1991 Sep; 165(1):43-51. PubMed ID: 1955934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues.
    Ofner D; Bankfalvi A; Riehemann K; Bier B; Böcker W; Schmid KW
    Mod Pathol; 1994 Dec; 7(9):946-50. PubMed ID: 7892164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of three-dimensional distribution of AgNOR proteins during interphase in leukemic cells.
    Wozniak ZM; Usson Y; Parazza F; Champelovier P; Leroux D; Seigneurin D
    Cytometry; 1996 May; 24(1):14-26. PubMed ID: 8723898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
    Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
    Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of DNA ploidy and proliferation rate in lung tumours by bromodeoxyuridine labelling index, S-phase fraction and AgNOR technique.
    Gasińska A; Biesaga B; Kołodziejski L; Słonina D
    Pol J Pathol; 1996; 47(4):201-7. PubMed ID: 9097713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of the nucleolar organizer region by silver staining (AgNOR method) in research and in histopathological practice.
    Kodousek R; Dusek J
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():9-37. PubMed ID: 1726500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores.
    Soomro IN; Whimster WF
    J Pathol; 1990 Nov; 162(3):217-22. PubMed ID: 2266458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between interphase AgNOR distribution and nucleolar size in cancer cells.
    Derenzini M; Farabegoli F; Trerè D
    Histochem J; 1992 Dec; 24(12):951-6. PubMed ID: 1283387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
    Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification.
    Trerè D; Migaldi M; Trentini GP
    Anal Cell Pathol; 1995 Jan; 8(1):57-65. PubMed ID: 7734412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar organizer regions and Ki-67 immunostaining in ductal breast cancer: a comparative study.
    Canepa M; Gambini C; Sementa AR; Borgiani L; Rovida S
    Pathologica; 1990; 82(1078):125-32. PubMed ID: 2168032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silver-binding nucleolar organizer regions (AgNORs) in tumors of colon.
    Zaczek M; Dabroś E; Szot W; Chłap Z
    Pol J Pathol; 1996; 47(4):195-200. PubMed ID: 9097712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
    Gasińska A; Zabagło L; Cichocka A; Pudełek J; Urbański K; Skołyszewski J
    Folia Histochem Cytobiol; 1996; 34(2):95-101. PubMed ID: 8875218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.
    Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC
    J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.